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ABSTRACT
2 Cocoa flavanols (CF) can improve flow-mediated dilation (FMD), blood pressure, and vascular 
3 stiffness in healthy subjects. Endothelial microparticles (EMPs) are markers of endothelial functional 
4 integrity reflecting activation and injury. In plasma samples, we investigated whether age-dependent 
5 changes in circulating EMPs exist and whether CFs decrease EMPs in healthy humans. The 
6 concentrations of CD31+/41-, CD144+, and CD62e+-EMPs (flow-cytometry) were increased in healthy 
7 elderly (n=19) as compared to young (n=20) non-smokers. EMPs correlated with age, systolic blood 
8 pressure, and pulse wave velocity. CD31+/41- and CD62e+-EMPs inversely correlated with FMD. 
9 Following 2 weeks twice-daily CF consumption (450 mg), CD31+/41- and CD144+-EMPs decreased 
10 both in young and elderly subjects compared to CF-free control. The EMP decrease inversely 
11 correlated with FMD improvements. Cardiovascular aging is associated with increased EMPs that can 
12 be modulated by dietary flavanols along with improvements in vascular function. This indicates that 
13 flavanol consumption can improve endothelial functional integrity in healthy humans. 
14 Key words: age; endothelial microparticles; endothelial function; nutrition; blood pressure; arterial 
15 stiffness 
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17 INTRODUCTION
18 Vascular aging is a complex continuous multifactorial process leading to gradual loss of vascular 
19 function and development of structural changes including arterial stiffness and loss of 
20 microvasculature. These changes promote the development of many age-related diseases and account 
21 for a large proportion of cardiovascular mortality.1 The mechanisms underlying vascular aging are not 
22 fully understood but involve all segments of the arterial vascular system and overlap with those of 
23 atherosclerosis and arteriosclerosis. An impairment in endothelial homeostasis may be a common 
24 central mechanism.2
25 More recently, interventions to slow cardiovascular aging have become an important focus of 
26 research aiming at prevention of cardiovascular disease.2 In this context, diet and specific plant 
27 bioactives may be of interest.3 In particular flavanols, a subgroup of dietary plant-derived bioactives 
28 that is mostly consumed with tea, pome fruits, berries, and cocoa products,4 have received much 
29 attention, as clinical studies indicate that a higher intake of flavanol-containing foods can not only 
30 improve arterial function in individuals at risk for cardiovascular disease (CVD) and with established 
31 CVD5, 6 but also healthy individuals over a broad age range.7, 8 These clinical intervention trials have 
32 shown that flavanols can improve cardiovascular parameters implied in vascular healthy aging 
33 including endothelial function, arterial stiffness, blood pressure, cholesterol, and potentially glycemic 
34 control.3, 9  For instance in the FLAVIOLA Health study, we have studied the effect of a dietary cocoa 
35 flavanol (CF) intervention on hallmarks of cardiovascular aging on major segments of the 
36 cardiovascular system, such as cardiac performance, endothelial dysfunction, increased systolic blood 
37 pressure, vascular stiffness, and microcirculatory functions in healthy humans.7, 8 The results showed 
38 that a 2-4 week CF intervention can reverse age-related burden of cardiovascular risk in healthy 
39 elderly and middle aged subjects with significant improvements in flow-mediated dilation and 
40 microvascular perfusion, decrease in systolic blood pressure, pulse wave velocity, and aortic 
41 augmentation index.7, 8 Whether these changes led to improved endothelial functional integrity in 
42 elderly humans is unknown so far. 
43 To further investigate the role of functional endothelial integrity in age-dependent vascular 
44 responses to CF, we measured circulating endothelial microparticles (EMPs), which are endothelium 
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45 specific biomarkers of functional integrity reflecting endothelial activation and injury,10-15 in samples 
46 from our previous study.7 Specifically, in the current analysis, we investigated (a) whether age-
47 dependent changes in circulating EMPs exist, (b) whether these correlate with parameters of vascular 
48 function and structure that change with age, and (c) whether the CF intervention also affected 
49 circulating EMPs along with improved vascular function in healthy humans.
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51 MATERIALS AND METHODS 
52 Study participants and study design
53 To determine the impact of age on circulating endothelial microparticles, we analyzed plasma samples 
54 from 20 young (<35 years) and 19 elderly (50-80 years) healthy male Caucasian adult subjects that 
55 were obtained during our previous study (Table 1).16 We then analyzed the impact of a 2-week cocoa 
56 flavanol intervention on plasma EMP concentrations. As previously published,16 both young and 
57 elderly participants were randomly assigned to either the CF intake group (FLAVANOL; 450 mg total 
58 flavanols twice daily) or a nutrients-matched CF-free group (CONTROL) based on a double-masked, 
59 parallel group study design (See supplemental table 1 for characteristics of individual groups). Plasma 
60 samples were taken after overnight fasting on day 1 and day 14.
61 The results and detailed methods of hemodynamic endpoints were previously published.16 
62 Briefly, central arteries, especially the aorta, were characterized by their physicomechanical properties 
63 estimating central blood pressure (BP), pulse wave velocity (PWV), and augmentation index (AIX) 
64 with the Sphygmocor device (AtCor Medical); office blood pressure was measured on the upper arm 
65 using a standard sphymomanometric cuff (Dynamap), conduit artery function was measured by 
66 ultrasound (Vivivi, GE) as brachial artery flow-mediated dilation (FMD) following 5 min occlusion of 
67 the forearm with a blood pressure cuff (Brachial Analyzer) and nitroglycerin-mediated vasodilation 
68 (NMD) at 3 min after 400 mg nitroglycerin SL (Nitrolingual, Pohl). Maximal perfusion of the 
69 cutaneous microcirculation was assessed by Laser Doppler perfusion imaging (Perimed) after 5 min of 
70 lower arm occlusion. The study protocol was approved by the ethics committee of the Heinrich-Heine-




75 As previously described in detail,16 both interventions provided by Mars, Inc. used a low-calorie fruit-
76 flavored beverage mix that was standardized and matched in composition. The CF-containing drink 
77 (FLAVANOL) provided 450 mg of total cocoa flavanols per serving.17 The total amount of CF in mg 
78 represents the sum of all monomeric flavanols and their oligomers (i.e., procyanidins) with a degree of 
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79 polymerization up to and including 10 (i.e. DP 1-10). (-)-Epicatechin was the predominant monomeric 
80 flavanol in this drink. Compositional details for the CONTROL and FLAVANOL test drinks are 
81 provided in Table 2.
82
83 Characterization of EMP subpopulations by flow cytometry
84 Six mL of cubital venous blood was drawn into citrate containing Vacutainer tubes and processed 
85 within 2 h. Platelet-rich plasma (PRP) was acquired by centrifugation of whole blood at 300 g over 15 
86 min at room temperature (RT). Platelet-free plasma (PFP) was obtained by 2 successive 
87 centrifugations of PRP at 10,000 g for 5 min at RT. As described previously, microparticle 
88 subpopulations were discriminated by flow cytometry according to the expression of established 
89 surface antigens.18 PFP was incubated for 30 min with fluorochrome-labeled antibodies or matching 
90 isotype controls and analyzed in a flow cytometer (VERSE, Beckton Dickinson, Heidelberg, 
91 Germany). Microbead standards (1.0 µm) were used to define an analysis gate consistent with the size 
92 of EMPs. Events of less than 1.0 µm diameter were identified in forward scatter and side scatter 
93 intensity dot representation, gated as microparticles, and then plotted on 1- or 2-color fluorescence 
94 histograms. The MP subpopulations were defined as elements that were  less than 1.0 µm in size and 
95 that were positively labeled by the specific antibodies for the endothelial surface markers 
96 CD31+/CD41-, CD144+, and CD62e+. The concentration of MPs was quantified by comparison of 
97 flow-count calibrator beads (20 µL) with a predetermined concentration and expressed as events per 
98 microliter PFP (Ev/µL).
99
100 Statistical methods
101 Demographics are given as mean and standard deviation. Results as mean and standard error of the 
102 mean. Young and elderly plasma EMP concentrations were compared using independent student t-test. 
103 Changes in EMP concentration (Delta) were calculated as 2-week concentration minus baseline 
104 concentrations for each individual. The primary test for an effect of CF was a two-way ANOVA (2 
105 between subject factors: intervention (CONTROL/FLAVANOL) and age (young/elderly). ANOVA 
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106 was performed with SPSS (V 24; IBM). Univariate correlations were Pearson’s r. P values of less than 
107 0.05 were regarded as statistically significant.
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109 RESULTS
110 Baseline demographic, clinical, and hemodynamic characteristics of young (26±3 years) and elderly 
111 (60±8 years, p<0.001) study subjects are presented in Table 1 and Supplemental Table 1 baseline 
112 characteristics split by treatment group). Note that values slightly differ from our previous 
113 publication,16 as only values of subjects with EMP data were included (young n=20; elderly n=19). All 
114 subjects were non-smokers, were non-diabetic, had no diagnosis, present or history of clinical 
115 symptoms of cardiovascular disease (dyspnea, angina, edema, claudication, palpitations). None were 
116 not taking regular medication or had a medical indication for blood pressure or cholesterol lowering 
117 medication. The elderly study group exhibited statistically significant greater body weight, fasting 
118 glucose, total and LDL cholesterol. Furthermore, the elderly had a higher diameter of brachial artery, 
119 office and central systolic blood pressure, central diastolic blood pressure, PWV, AIX, and lower 
120 FMD and maximal microvascular perfusion. 
121 As depicted in Table 3, age correlated with fasting glucose, BMI, total cholesterol and LDL 
122 cholesterol. Positive correlations existed between age and brachial artery diameter, office and central 
123 blood pressure, PWV, and AIX. Inverse correlations existed between age and FMD and maximal 
124 microvascular perfusion. 
125
126 Age-related increase in circulating concentrations of endothelial microparticles 
127 Young subjects exhibited significantly lower concentrations of CD31+/41-, CD144+, and CD62e+ 
128 EMPs in plasma than elderly subjects (Figure 1). EMPs and age showed significant inverse 
129 correlations (Table 3). We observed statistically significant correlations of between EMP 
130 concentrations and hemodynamic parameters that go along with increased mechanical stress of large 
131 arteries including systolic blood pressure, PWV, and AIX.
132
133 Flavanol intervention decreases EMPs in healthy young and elderly humans and is associated 
134 with improvements in endothelial function
135 FLAVANOL intake led to a significant decrease of CD31+/41- (main effect p=0.003), CD144+ 
136 (p=0.001), and CD62e+-EMPs (p=0.006) in both young and elderly subjects as compared to 
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137 CONTROL (Figure 2). The interaction between age and intervention were not statistically significant 
138 suggesting that the effect size did not differ with age (CD31+/41-: p=0.691; CD144+: p=0.813; CD62+: 
139 p=0.489). As previously reported, FLAVANOL led to a statistically significant increase in FMD and 
140 microvascular perfusion and lowering in cholesterol, blood pressure, and PWV both in young and 
141 elderly healthy subjects.19 AIX was only significantly decreased in elderly.19 We observed significant 
142 inverse correlations between changes in FMD and EMPs (Table 4). Furthermore, the changes in 
143 CD31+/41- and CD62e+-EMPs correlated with the changes in central systolic blood pressure. The 
144 changes in PWV correlated with the changes in CD144+ and CD62e+-EMPs.
145
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147 DISCUSSION
148 Our data demonstrate that at baseline the levels of circulating endothelial microparticles were higher 
149 with age and correlated with hemodynamic parameters associated with ageing. Furthermore, our data 
150 show that a 2-week cocoa flavanol intervention significantly decreased EMPs in both healthy young 
151 and elderly volunteers and the changes in EMPs correlated with improvements of hemodynamic 
152 parameters.
153 In the presence of cardiovascular risk factors, concerted with a genetic disposition and 
154 environmental factors, the arterial endothelium loses its normal regulatory function for vessel wall 
155 homeostasis; a concept termed ‘endothelial dysfunction’.20 Cardiovascular risk factors appear to 
156 converge both in positive, but also in negative ways, on the vascular endothelium with significant 
157 effects on the progression vascular aging.21 Flow-mediated dilation is an establish methodology to 
158 measure endothelium-dependent vasodilation as a surrogate marker for cardiovascular risk. However, 
159 FMD measures the capacity of an artery to dilate in response to stimulus and this can be affected by 
160 non-endothelial factors such as the response of smooth muscle cells or structural components of the 
161 arterial wall. EMPs can be seen as circulating biomarkers of a compromised endothelial integrity that 
162 are released from activated and apoptotic endothelial cells.13, 14 Circulating levels of EMPs increase in 
163 plasma early in atherosclerotic processes, correlate with the degree of endothelial dysfunction,22 and 
164 have been established as prognostic biomarkers that predict adverse CV outcome.23-25 Cardiovascular 
165 risk factors including hypertension, hypercholesterolemia, and smoking were shown to trigger EMP 
166 release.26, 27 The current study is the first to demonstrate that EMPs are age-dependently increased in 
167 healthy humans and that EMPs correlate with changes in hemodynamic parameters that occur during 
168 healthy aging. We propose that, this increase may be due to endothelial activation (CD62e+), ongoing 
169 mechanical endothelial injury (CD144+), or impaired vascular protection due to lowered wall shear 
170 stress (CD31+/41-) similar to arterial hypertension.10 
171 A number of clinical intervention studies have shown that the intake of flavanol-containing 
172 foods or isolated flavanols can improve cardiovascular risk biomarkers including FMD and blood 
173 pressure in individuals at risk for CVD, with established CVD5, 6, and healthy individuals at low CVD 
174 risk over a broad age range.7, 8 Although the mechanisms of action underlying the biological effects of 
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175 flavanols are not completely understood, flavanols are one of a few bioactives known today, for which 
176 causality between the intake and an improvement in FMD has been demonstrated.28 As FMD reflects 
177 endothelium-dependent vasodilation,29 improvements in FMD are paralleled by increased plasma 
178 concentrations of nitric oxide species,6, 30 and FMD improvements were inhibited by intravenous 
179 application of an nitric oxide synthase inhibitor30 it is currently believed that cardiovascular effects of 
180 flavanols may be due to effects on the vascular endothelial cells.29 Only a few studies are available on 
181 the effect of bioactives on EMPs in humans.31-33 We have previously shown in patients with coronary 
182 artery disease that CF related improvements in FMD and circulating nitric oxide species were 
183 paralleled by significant decreases in circulating EMPs supporting the concept that flavanols may 
184 improve endothelial integrity in patients with CVD.33 In the current manuscript, we extend these 
185 findings to healthy young and elderly humans supporting that CF specifically increase functional 
186 endothelial integrity not only in patients with coronary artery disease,33 but also healthy people. 
187 Furthermore, as CD62e+ is exclusively expressed on the surface of activated endothelial cells, a 
188 decrease in CD62e+ EMPs as seen in our present work can be cautiously interpreted as a decrease in 
189 endothelial inflammation or activation even in ‘healthy ‘ humans.32 Others have shown in vitro,34 that 
190 nitric oxide can blunt EMP release via ABCA1 expression and cytoskeletal reorganization offering a 
191 potential mechanism of how CF may decrease EMPs; a hypothesis that awaits in vivo. 
192 Taken together, we conclude that healthy human cardiovascular aging is associated with 
193 increased endothelial microparticles along with decreased vascular function that can be modulated by 
194 a dietary flavanol intervention along with improvements in vascular function. Our data further support 
195 that an intervention with dietary CF improves endothelial functional integrity in healthy humans. 
196
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328 Table 1: Baseline (A) clinical and (B) hemodynamic characteristics of study population (mean [SD], 
329 t-test; AIX = aortic augmentation index; BA = brachial artery; BMI = body mass index; CRP = C-
330 reactive protein; DBP = diastolic blood pressure; FMD = flow-mediated dilation; Hb = hemoglobin; 
331 HDL = high density lipoprotein; HR = heart rate; LDL = low density lipoprotein; NMD = 
332 nitroglycerin mediated dilation; PU = perfusion units; PWV = pulse wave velocity; SBP = systolic 
333 blood pressure) 
  Young Elderly p-value
A n  20   19   
 Age (y) 26 ± 3 60 ± 8 <0.001
 BMI (kg/m2) 24.1 ± 2.3 26.5 ± 3.2 0.011
 Height (m) 1.82 ± 0.06 1.82 ± 0.05 0.691
 Weight (kg) 80 ± 10 87 ± 12 0.044
 Creatinine (mg/dL) 1.0 ± 0.1 1.0 ± 0.1 0.729
 Total cholesterol (mg/dL) 185 ± 35 223 ± 32 0.001
 LDL cholesterol (mg/dL) 130 ± 26 152 ± 27 0.029
 HDL cholesterol (mg/dL) 54 ± 17 54 ± 12 0.916
 Triglycerides (mg/dL) 98 ± 46 119 ± 40 0.123
Fasting plasma glucose (mg/dL) 89 ± 8 94 ± 8 0.045
 HbA1c (%) 4.8 ± 1.2 4.5 ± 2.0 0.533
 CRP (mg/dl) 0.1 ± 0.2 0.05 ± 0.1 0.214
 Hb (mg/dl) 15.2 ± 0.9 15.4 ± 1.1 0.516
 Leucocytes (1,000 /μL) 5.3 ± 1.2 5.7 ± 1.4 0.332
B BA resting diameter (mm) 4.40 ± 0.26 4.90 ± 0.48 <0.001
 FMD (%) 6.3 ± 0.6 5.1 ± 0.8 <0.001
 NMD (%) 14.9 ± 1.3 12.8 ± 1.7 0.004
 HR (bpm) 56 ± 8 56 ± 7 0.780
 Office SBP (mmHg) 121 ± 6 130 ± 11 0.003
 Office DBP (mmHg) 77 ± 7 82 ± 9 0.073
 Central SBP (mmHg) 104 ± 7 124 ± 14 <0.001
 Central DBP (mmHg) 77 ± 7 84 ± 9 0.016
 PWV (m/s) 5.9 ± 0.5 9.3 ± 1.3 <0.001
 AIX (%) -8 ± 9 23 ± 8 <0.001
 Microvascular perfusion baseline (PU) 41 ± 14 40 ± 8 0.798
 Microvascular perfusion maximum (PU) 264 ± 52 184 ± 36 <0.001
334
Table 2: Composition of 
interventional vehicles ingested bi-
daily (ND=not detectable) as used 
in previous studies.8, 19, 35, 36
FLAVANOL CONTROL
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Total cocoa flavanols (mg)* 450 ND
Monomers (mg)** 73 ND
(-)-Epicatechin (mg)** 64 ND
(-)-Catechin (mg)** 7 ND
(+)-Catechin (mg)** 2 ND
(+)-Epicatechin (mg)** ND ND
Dimers-decamers (mg)* 377 ND
Theobromine (mg)*** 44 46
Caffeine (mg)*** 10 6
Fat (g)# 0 0
Carbohydrates (g) ## 6 6
Protein (g) # 0.1 0.1
Energy (kcal) # 25 25
Sodium (mg) # 3 3
Potassium (mg) # 95 85
335
336 *Content determined using method by Adamson et al.,17 with a %RSD (percent relative standard 
337 deviation) of 6%; **Content determined using method by Machonis et al.,37 with a %RSD of 2%, 3%, 
338 and 10% for (–)-epicatechin, (–)-catechin and (+)-catechin, respectively; ***Typical %RSD of 3% are 
339 observed for both caffeine and theobromine; #Macronutrients were determined using AOAC-
340 accredited methods used for nutritional product labelling. ## Content determined using Total 
341 Carbohydrate by difference method. 
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342 Table 3: Univariate correlations between age, CD31+/41-, CD144+, and CD62e+ endothelial microparticles (EMPs), clinical, and hemodynamic parameters. (r is 
343 Pearson’s correlation coefficient; Ev/L = events on flow cytometry analysis per microliter platelet free plasma; AIX = aortic augmentation index; BA = brachial 
344 artery; DBP = diastolic blood pressure; FMD = flow-mediated dilation; HDL = high density lipoprotein; LDL = low density lipoprotein; PU = perfusion units; 
345 PWV = pulse wave velocity; SBP = systolic blood pressure)
  Age (y)
CD31+/41- 
(Ev/L) CD144+  (Ev/L) CD62e+  (Ev/L)
  r p r p r p r p
A Age (y)   0.37 0.019 0.38 0.018 0.53 0.001
 Fasting plasma glucose (mg/dL) 0.39 0.013 0.30 0.067 0.23 0.150 0.28 0.083
 BMI (kg/m2) 0.42 0.008 0.32 0.047 0.23 0.163 0.33 0.043
 Triglycerides (mg/dL) 0.24 0.149 0.32 0.046 0.07 0.657 0.20 0.226
 Total cholesterol (mg/dL) 0.55 <0.001 0.14 0.395 0.20 0.217 0.28 0.088
 LDL cholesterol (mg/dL) 0.41 0.021 0.10 0.597 0.20 0.285 0.42 0.017
 HDL cholesterol (mg/dL) 0.03 0.889 -0.28 0.121 -0.17 0.365 0.32 0.072
 Leucocytes (1,000 /L) 0.22 0.184 0.39 0.015 0.08 0.644 0.32 0.049
          
B HR (/min) 0.07 0.698 0.01 0.940 -0.21 0.229 -0.15 0.395
 BA resting diameter (mm) 0.59 <0.001 0.21 0.209 0.05 0.722 0.47 0.003
 FMD (%) -0.40 0.011 -0.39 0.013 0.05 0.744 -0.28 0.048
 Office SBP (mmHg) 0.43 0.007 0.38 0.016 0.34 0.032 0.32 0.047
 Office DBP (mmHg) 0.32 0.046 0.19 0.236 0.21 0.195 0.17 0.292
 Central SBP (mmHg) 0.68 <0.001 0.44 0.005 0.43 0.007 0.42 0.008
 Central DBP (mmHg) 0.43 0.007 0.10 0.571 0.24 0.146 0.3 0.061
 PWV (m/s) 0.82 <0.001 0.42 0.008 0.35 0.031 0.41 0.010
 AIX (%) 0.81 <0.001 0.45 0.004 0.28 0.087 0.47 0.002
 Microvascular perfusion maximum (PU) -0.67 <0.001 -0.41 0.011 -0.35 0.033 -0.46 0.004
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347 Table 4: Univariate correlations between changes in CD31+/41-, CD144+, and CD62e+ endothelial microparticles (EMPs), clinical and hemodynamic parameters. 
348 (r is Pearson’s correlation coefficient; Ev/L = events on flow cytometry analysis per microliter platelet free plasma; AIX = aortic augmentation index; BA = 
349 brachial artery; DBP = diastolic blood pressure; FMD = flow-mediated dilation; PU = perfusion units; PWV = pulse wave velocity; SBP = systolic blood 
350 pressure)
351
 CD31+/41- (Delta Ev/L) CD144+  (Delta Ev/L) CD62e+  (Delta Ev/L)
 r p r p r p
Total cholesterol (Delta mg/dL) 0.19 0.244 0.07 0.687 0.17 0.310
BA resting diameter (Delta mm) 0.19 0.253 -0.19 0.257 0.14 0.393
FMD (Delta %) -0.39 0.015 -0.51 0.001 -0.48 0.002
Office SBP (Delta mmHg) 0.03 0.871 0.25 0.125 0.20 0.228
Office DBP (Delta mmHg) 0.29 0.069 0.23 0.151 0.23 0.155
Central SBP (Delta mmHg) 0.34 0.035 -0.01 0.962 0.37 0.022
Central DBP (Delta mmHg) 0.18 0.275 -0.01 0.975 0.19 0.243
PWV (Delta m/s) 0.12 0.466 0.36 0.027 0.56 <0.001
AIX (Delta %) 0.30 0.064 0.32 0.048 0.19 0.245
Microvascular perfusion maximum (Delta PU) -0.06 0.744 -0.21 0.196 0.01 0.953
352
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353 FIGURE LEGENDS
354 Graphic for table of contents
355
356 Figure 1: Concentrations of circulating endothelial microparticles (CD31+/41-, CD144+, CD62e+) 
357 are increased in elderly as compared to young subjects. Values are mean +/- SEM of events on 
358 flow cytometry analysis per microliter platelet free plasma (Ev/μL), * p vs YOUNG <0.05 (t-test). 
359 Figure 2: Change in concentrations of circulating endothelial microparticles (CD31+/41-, 
360 CD144+, CD62e+) in young and elderly following 2 weeks of twice daily cocoa flavanol ingestion. 
361 Values are mean change +/- SEM of events on flow cytometry analysis per microliter platelet free 
362 plasma (Ev/μL), * p FLAVANOL vs CONTROL <0.05. (ANOVA; interaction between treatment and 
363 group were not statistically significant in all microparticle subgroups)
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